Innocutis has launched its newest product, Sitavig

INNOCUTIS has launched its newest product, Sitavig (acyclovir) 50 mg buccal tablets. Sitavig uses Lauriad technology, which consists of a tablet that sticks to the gum, above the canine tooth on the side of the lip that is infected with a cold sore, according to the company. This white- to slightlyyellow tablet is tasteless and odorless. It dissolves to provide a sustained release of medicine.

www.innocutis.com